Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Resistance to PD-1 blockade in melanoma
Antoni Ribas
UCLA Medical Ctr., Los Angeles, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
Resistance to PD-1 blockade in MSI-H tumors
Luis A. Diaz
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
Genomic and neoantigen landscape of response and resistance to immune checkpoint blockade
Victor E. Velculescu
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
Inactivation of DNA repair to improve immune surveillance
Alberto Bardelli
Univ. of Turin School of Medicine, Candiolo, Italy
from 2017 Molecular Targets and Cancer Therapeutics conference on October 27, 2017 4:30 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4